| Symbol | FRLI |
|---|---|
| Name | FRELII, INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 84043 United States UT 2701 North Thanksgiving Way Suite 100 |
| Telephone | (833) 437-3544 |
| Fax | — |
| — | |
| Website | https://www.frelii.com |
| Incorporation | US |
| Incorporated On | 2002 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Michael T. Studer CPA P.C.; |
| Audit Status | AUDITED |
| Reporting Status | U.S. Reporting: SEC Reporting |
| CIK | 0001223533 |
| Description | Frelii Inc. is a biotech company that uses human DNA gene sequencing and artificial intelligence (AI) to assess more than 3.2 billion markers on the human genome. The results are aligned and leveraged against its AI, as a means of creating a very strong and powerful data platform for use by the Health & Wellness, Healthcare, Medical Cannabis and Pharmaceutical industries. Freliis technology generates accurate and profoundly valuable insight into an individuals DNA. The company provides DNA Kit Packages and customized reporting for consumers, patients and healthcare providers to ensure the ideal treatment, drugs and dosing are a prime "fit" to the individual. Additional info from OTC: |
No news found.